Online Ticketing powered by Eventbrite

News & Events

Benchmark Interim Results Webinar, Thursday 26th June, 1pm

The management of Benchmark Holdings (AIM: BMK) will be hosting a webinar on Thursday 26th June, 1pm, to discuss their results for the half year to March 2014. Malcolm Pye, CEO, Roland Bonney, COO, and Mark Plampin, CFO, will give a 20 minute presentation with an opportunity for Q&A at the end. 

Register here

If you would like to submit any questions for management in advance of the webinar please send them to hannah@equitydevelopment.co.uk

-------------------------------------------------------------------------------------

Equity Development Investor Forum, Wednesday 11th June at 5pm: Tristel, Regenersis and Sinclair IS Pharma

We hosted our next Investor Forum at Fasken Martineau, on the evening of Wednesday 11th June. You are invited to attend and meet the senior management of Tristel, Regenersis, and Sinclair IS Pharma.

Eventbrite - Equity Development Investor Forum
 
Tristel (TSTL)
On the back of today's further upgrade in market expectations, Tristel are riding high. Focused on infection, hygiene and contamination control products, and with their own patented chlorine dioxide chemistry, their products are in use in c.400 hospitals. It is the strong recurring nature of revenues which can provide investors with the expectation that the performance to date is forecast to continue. CEO, Paul Swinney and CFO, Liz Dixon, presented the case for continued growth.
 

Regenersis (RGS)
Regenersis was already the EMEA's leader for the repair and refurbishment of electronic devices, but it has also recently entered the exciting 'data erasure' market. That was achieved by the purchase of Finnish cyber expert, Blancco, helped by a 100m equity placing. CFO, Jog Dhody explained the opportunities ahead for the Group.
 

Sinclair IS Pharma (SPH)
Sinclair IS is an international specialty pharmaceutical company centred on Dermatology, in particular - Aesthetics, Wound care, and Skin Care. Under a dynamic management team it has successfully completed a series of significant and earnings enhancing product acquisitions over the last 12 months: it now owns a leading product portfolio in their chosen and rapidly growing products' market. Chris Spooner, CEO, updated our audience.
 
Venue: Fasken Martineau, 17 Hanover Square, London, W1S 1HU

Date: Wednesday 11th of June

Please contact: Hannah@equitydevelopment.co.uk with any questions.


 

HEDGE FUND MANAGERS | HEDGE FUND ANALYSTS | HEDGE FUND RESEARCHERS | FINANCIAL MARKET RESEARCHERS | COMPANY VALUES RESEARCH | LISTED COMPANIES RESEARCH FIGURES | COMPANY PERFORMANCE RESEARCH | INVESTMENT ROAD SHOWS | PRIVATE COMPANIES RESEARCH FIGURES | COMPANY RESEARCH DATA | INVESTMENT SECTORS NEWS | INVESTMENT MARKET COMMENT | EQUITY DEVELOPMENT, LONDON | EQUITY DEVELOPMENT NEWS | INVESTMENT NEWS |